Anti-Progesterone antibody [1801] (STJ400162)

SKU:
STJ400162
£376.50 - £858.50
Free Shipping
Processing The item has been added

Short Description :Mouse monoclonal anti-Progesterone for use in FIA in Progesterone samples. Datasheet included with dilution recommendations, and related reagents.
Applications:FIA
Host:Mouse
Reactivity:Progesterone
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Monoclonal
Clone ID :1801
Isotype:IgG1
Conjugation:Unconjugated
Concentration:5.0 mg/ml (+/-10 %)
Formulation:50 mM citrate, pH 6.0, 0.9 % NaCI, 0.05 % Sulfobetaine, 0.095 % NaN3 as a preservative
Storage Instruction:Store at 2–8 °C, and do not freeze.
Immunogen:Not determined
Specificity:Antibody recognizes progesterone. 21-hydroxyprogesterone 5 %, 17-alpha-hydroxyprogesterone 2 %, 11-alpha-hydroxyprogesterone 0, 5 %, 17-alpha-hydroxypregnenolone 0 %
Background Progesterone is produced after ovulation in the corpus luteum and during pregnancy in the placenta. It is also produced in the adrenal glands. In women, progesterone levels are relatively low during the preovulatory phase, rise after ovulation, and are elevated during the luteal phase. Progesterone levels tend to be < 2 ng/ml prior to ovulation, and > 5 ng/ml after ovulation. If pregnancy occurs, progesterone levels are initially maintained at luteal levels. With the onset of the luteal-placental shift in progesterone support of the pregnancy, levels start to rise further and may reach 100–200 ng/ml at term. After delivery and during lactation, progesterone levels are very low. Progesterone levels are relatively low in children and postmenopausal women. Adult males have levels similar to those in women during the follicular phase of the menstrual cycle.

Information sourced from Uniprot.org